Macleods recalls 32 lots of losartan

Macleods Pharmaceuticals is recalling 32 lots of losartan potassium tablets and losartan potassium/hydrochlorothiazide tablets. 

The recall was prompted after a potentially carcinogenic impurity, N-Nitroso-N-methyl-4-aminobutyric acid, was detected in the medication, which is used to treat high blood pressure. 

The drugmaker hasn't received any reports of adverse events related to the recalled products. 

Macleods is the latest drugmaker to recall its generic heart drugs over the detection of a potential carcinogen. 

Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.

 

Featured Learning Opportunities

Featured Whitepapers

Featured Webinars